Upward Trajectory: Galectin Therapeutics Inc (GALT) Posts a Slidee, Closing at 2.33

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

The closing price of Galectin Therapeutics Inc (NASDAQ: GALT) was $2.33 for the day, down -0.85% from the previous closing price of $2.35. In other words, the price has decreased by -$0.85 from its previous closing price. On the day, 1.94 million shares were traded. GALT stock price reached its highest trading level at $2.63 during the session, while it also had its lowest trading level at $2.3.

Ratios:

Our analysis of GALT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.08 and its Current Ratio is at 0.08.

On August 13, 2020, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $9 to $12.

On February 13, 2019, B. Riley FBR started tracking the stock assigning a Buy rating and target price of $11.B. Riley FBR initiated its Buy rating on February 13, 2019, with a $11 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 30 ’24 when Shlevin Harold H. bought 6,500 shares for $1.16 per share. The transaction valued at 7,540 led to the insider holds 15,206 shares of the business.

Jamil Khurram sold 13,654 shares of GALT for $12,044 on Dec 23 ’24. The Chief Medical Officer now owns 26,346 shares after completing the transaction at $0.88 per share. On Dec 23 ’24, another insider, LEWIS JOEL, who serves as the President and CEO of the company, sold 56,000 shares for $0.89 each. As a result, the insider received 49,610 and left with 897,012 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GALT now has a Market Capitalization of 147469424 and an Enterprise Value of 250689392.

Stock Price History:

The Beta on a monthly basis for GALT is 0.70, which has changed by -0.008510649 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, GALT has reached a high of $3.90, while it has fallen to a 52-week low of $0.73. The 50-Day Moving Average of the stock is 52.91%, while the 200-Day Moving Average is calculated to be 26.31%.

Shares Statistics:

GALT traded an average of 543.01K shares per day over the past three months and 2638910 shares per day over the past ten days. A total of 63.29M shares are outstanding, with a floating share count of 43.42M. Insiders hold about 31.40% of the company’s shares, while institutions hold 15.75% stake in the company. Shares short for GALT as of 1749772800 were 8954593 with a Short Ratio of 16.49, compared to 1747267200 on 8667591. Therefore, it implies a Short% of Shares Outstanding of 8954593 and a Short% of Float of 23.74.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.